abstract |
The invention refers to the use of a strain of Lactobacillus in particular Lactobacillus plantarum 299 (DSM 6595) or Lactobacillus plantarum 299 v (DSM 9843), giving to rise or increased amounts of propionic acid or acetic acid in colon for the preparation of a medicament reducing the risk factors involved in the metabolic syndrome, especially increasing the level of HDL cholestero l in serum, and reducing the levels of LDL, insulin and leptin, as well as a high blood pressure. |